Back to User profile » Dr Craig LaForce

Papers published by Dr Craig LaForce:

Original Research

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1819-1831

Published Date: 1 June 2018

Original Research

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

LaForce C, Feldman G, Spangenthal S, Eckert JH, Henley M, Patalano F, D’Andrea P

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1233-1243

Published Date: 8 June 2016

Original Research

Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect

Siler TM, LaForce CF, Kianifard F, Williams J, Spangenthal S

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:919-925

Published Date: 1 September 2014